Loading…
KAZANO is a brand name for Alogliptin, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
, Endocrine and Metabolism, Lactic Acidosis 04/2026 Table of Contents Sections or subsections that are not applicable at the time of authorization are not listed. Recent Major Label Changes ....................................................................................................
2 Table of Contents ..................................................................................................................... 2 Part 1: Healthcare Professional Information ............................................................................
5 1. Indications ......................................................................................................................... 1. Pediatrics ...............................................................................................................
2. Geriatrics ............................................................................................................... 5 2. Contraindications ..............................................................................................................
5 3. Serious Warnings and Precautions Box ............................................................................. 6 4. Dosage and Administration ...............................................................................................
1. Dosing Considerations ........................................................................................... 2. Recommended Dose and Dosage Adjustment ........................................................ 4. Administration .......................................................................................................
5. Missed Dose .......................................................................................................... 8 5. Overdose ...........................................................................................................................
8 6. Dosage Forms, Strengths, Composition and Packaging ..................................................... 9 7. Warnings and Precautions .................................................................................................
9 General .............................................................................................................................. 9 Cardiovascular ...................................................................................................................
9 Driving and Operating Machinery .................................................................................... 10 Endocrine and Metabolism ..............................................................................................
10 Hematologic .................................................................................................................... 13 Hepatic/Biliary/Pancreatic ...............................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Alogliptin in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
13 Immune ........................................................................................................................... 14 Monitoring and Laboratory Tests .....................................................................................
15 Neurologic ....................................................................................................................... 15 KAZANO® Alogliptin and Metformin Hydrochloride Tablets Page 3 of 63 Unclassified / Non classifié Perioperative Considerations ...........................................................................................
15 Renal ............................................................................................................................... 15 Reproductive Health ........................................................................................................
16 Skin .................................................................................................................................. 1. Special Populations ..............................................................................................
1. Pregnancy .................................................................................................... 2. Breastfeeding ............................................................................................... 3. Pediatrics .....................................................................................................
4. Geriatrics ..................................................................................................... 17 8. Adverse Reactions ...........................................................................................................
1. Adverse Reaction Overview ................................................................................. 2. Clinical Trial Adverse Reactions ............................................................................ 3. Less Common Clinical Trial Adverse Reactions .....................................................
4.
Abnormal Laboratory Findings:
Hematologic, Clinical Chemistry and Other Quantitative Data ............................................................................................................ 5. Post-Market Adverse Reactions ...........................................................................
24 9. Drug Interactions ............................................................................................................. 2. Drug Interactions Overview .................................................................................
3. Drug-Behavioural Interactions ............................................................................. 4. Drug-Drug Interactions ........................................................................................ 5. Drug-Food Interactions ........................................................................................
6. Drug-Herb […]